Introduction {#S0001}
============

Peripheral nerve trauma is a significant cause of morbidity and remains a great challenge in the clinic \[[@CIT0001]\]. After the trauma, the peripheral nerve is hard repair due to the following reasons: the degeneration of motor neurons, the lack of a survival environment for Schwann cells, and the poor ability of the nerve to regenerate \[[@CIT0002]\]. The generation of endogenous neurotrophic factors such as brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF) is known to play a critical role in supporting axon regeneration during peripheral nerve repair \[[@CIT0003], [@CIT0004]\]. Dexamethasone and vitamin B~12~ are currently used in the clinic to treat peripheral nerve damage but their mechanisms of action remain incompletely understood. In this study we hypothesized that dexamethasone and vitamin B~12~ have synergistic effects to promote the production of endogenous neurotrophic factors, thereby enhancing peripheral nerve repair.

Therefore, we used a rat model of peripheral nerve injury and demonstrated that dexamethasone and vitamin B~12~ synergistically enhanced the expression of BDNF and promoted the regeneration of myelinated nerve fibers and the proliferation of Schwann cells after injury of the sciatic nerve in rats.

Material and methods {#S0002}
====================

Animal models and experimental groups {#S20003}
-------------------------------------

Ninety-six adult male Wistar rats (6 weeks old, 180-200 g) were provided by the Animal Center of Liaoning Medical University. The rats were randomly divided into 4 groups (*n* = 24) and anesthetized with an intraperitoneal injection of 10% chloral hydrate (3 ml/kg body weight), then shaved and washed with antiseptic solution before positioning for surgery. The left sciatic nerve and its two major branches were exposed through a gluteal muscle-splitting incision. A crush injury was created using a fine watchmaker forceps for 10 s on the peroneal nerve at 10 mm from the extensor digitorum longus muscle and complete crush was confirmed by presence of a translucent band across the nerve. The incision was then closed in layers (muscle and skin) with absorbable sutures. All operations were performed on the left limb and the right limb served as a non-operated control. After the surgery, the rats were treated as follows: group A -- 0.9% saline was injected into the injured site; group B -- dexamethasone (1 mg/kg) was injected into the injured site; group C -- vitamin B~12~ (2 mg/kg) was injected into the injured site; and group D -- dexamethasone (1 mg/kg) and vitamin B~12~ (2 mg/kg) were injected into the injured site. The injection was performed once daily for 28 days. At 1, 3, 7, 14, 21 and 28 days, 4 rats were randomly selected from each group for sciatic functional index (SFI) and sensory nerve conduction velocity (SCV) tests, then the rats were sacrificed and 1 cm of the left sciatic nerve was immediately taken from each rat as experimental samples. In addition, 1 cm of the right sciatic nerve was immediately taken from each rat as experimental samples.

Walking track analysis {#S20004}
----------------------

At 1, 3, 7, 14, 21 and 28 days, the rats were put on a walking track (15 cm × 50 cm) darkened at one end. White office paper cut to the appropriate dimensions was placed on the bottom of the track. The rat\'s hind limbs were dipped in Chinese ink, and the rat was permitted to walk down the track, leaving its hind foot prints on the paper. The SFI value was calculated based on the analysis of walking tracks as described previously \[[@CIT0005]\]. Functional recovery was assessed by calculating SFI ratio with SFI value of 0 set as normal and SFI value of (--) 100 set as complete injury.

Electrophysiological analysis {#S20005}
-----------------------------

At 1, 3, 7, 14, 21 and 28 days, the rats were anesthetized with chloral hydrate and the SCV of the left sciatic nerve was measured using a Cantata electromyograph (DANTEC Medical, Denmark) as described previously \[[@CIT0006]\].

Immunohistochemical analysis {#S20006}
----------------------------

The sciatic nerves were fixed in 10% formaldehyde and were paraffin wax-embedded. Subsequently, the tissues were cut into 5 µm thick serial sections, which were washed carefully with phosphate buffered saline (PBS) three times. To block endogenous peroxidases, dewaxed paraffin sections were treated with 3% hydrogen peroxide for 20 min. The sections were blocked with 2% goat serum in PBS for 1 h at room temperature, then incubated at 4°C overnight with rabbit antibody against human BDNF, GDNF, neurotrophin-3 (NT-3), and interleukin-6 (IL-6) (1: 250 dilution, Santa Cruz Biotechnology, Santa Cruz, CA, USA). Afterwards, the sections were washed with PBS and subjected to immunohistochemical staining using a PV6000 kit (Bioss Inc. Beijing, China). Next, the sections were washed with PBS and developed with 3,3'-diaminobenzidine (DAB) for 5 min. Finally the sections were counterstained by hematoxylin and assessed by two independent investigators under light microscopy. The staining density was calculated based on the absorbance (A) value of the nerves using an image analysis system.

RT-PCR analysis {#S20007}
---------------

Total RNA was extracted from the sciatic nerves using Trizol (Invitrogen, Carlsbad, CA, USA) following the manufacturer\'s protocol. cDNA was produced by reverse transcription using an RT kit (Takara, Shiga, Japan) following the manufacturer\'s protocol. PCR amplification of BDNF, GDNF, NT-3, IL-6 and β-actin was done with Taq Master Mix (Promega, Madison, WI, USA) with cDNA synthesized from the nerves. The primers were synthesized by Takara (Dalian, China) with the following sequences: BDNF 5'-CATGT CTATG AGGGT TCGGC-3' and 5'-AAGTT GTGCG CAAAT GACTG-3', amplicon 581 bp; GDNF 5'-CCG GAC GGG ACT CTA AGA TGA-3' and 5'-GTC AGG ATA ATC TTC GGG CAT ATT G-3', amplicon 256 bp; NT-3 5'-CGGATGCCATGGTTACTTCT-3' and 5'-GATATCCGCCTGGATCAACT-3', amplicon 176 bp; IL-6 5'-CTCCATCTGCCCTTCA-3' and 5'-CCAGGATAGAGCCACCAAT-3', amplicon 569 kb; β-actin 5'-GTTCG CCATG GATGA CGATA TC-3' and 5'-GCCAG ATCTT CTCCA TGTCG TC-3', amplicon 256 bp. Amplification conditions were as follows: 5 min at 95°C (one cycle) and 40 s at 94°C; 40 s at the annealing temperature (56.8°C for BDNF, 61.1°C for GDNF, 59.2°C for NT-3, 58.3°C for IL-6, and 58.8°C for β-actin); and 1 min at 72°C (35 cycles) and 72°C for 5 min (one cycle). PCR products were analyzed by 1.5% gel electrophoresis followed by densitometric analysis of band intensity. The relative mRNA levels were determined with β-actin as the internal control.

Electron microscopy {#S20008}
-------------------

The sciatic nerves were extracted from different groups of rats, fixed by osmium tetroxide, dehydrated by acetone, and sliced into 0.5 µm ultra thin sections. The sections were dual stained by uranium acetate and lead citrate. The ultrastructure of the nerves was examined by JEM 2000 EX transmission electron microscope (JEOL, Japan).

Statistical analysis {#S20009}
--------------------

The data were expressed as mean ± standard deviation and analyzed by SPSS 13.0 software. Single factor analysis of variance was used for the comparisons among the groups. Value of *p* \< 0.05 was considered as statistically significant.

Results {#S0010}
=======

Dexamethasone and vitamin B~12~ synergistically promote the recovery of SFI in the injured sciatic nerves {#S20011}
---------------------------------------------------------------------------------------------------------

Walking track analysis demonstrated that 1 day after the injury, SFI values in different groups showed no significant differences. However, 14 days after the injury, SFI value was recovered by 25.43 ±2.3%, 24.92 ±1.6%, and 28.76 ±2.5% in group B, C and D, respectively, significantly higher than in group A (20.12 ±1.2%) (*p* \< 0.05), but showed no differences among group B, C and D (*p* \> 0.05). Furthermore, 28 days after the injury, SFI value was recovered by 46.79 ±1.6%, 48.43 ±1.7%, and 59.37 ±2.8% in group B, C and D, respectively, significantly higher than in group A (37.83 ±3.1%) (*p* \< 0.05). In addition, at this time the recovery of SFI value was significantly higher in group D than in group B and C (*p* \< 0.05) with no significant difference between group B and C (*p* \> 0.05) ([Figure 1](#F0001){ref-type="fig"}). These results suggest that dexamethasone and vitamin B~12~ synergistically promoted the recovery of SFI in the injured sciatic nerves.

![Recovery of SFI in injured sciatic nerves in different groups at different times after the injury\
Group A -- 0.9% saline treatment, group B -- dexamethasone (1 mg/kg) treatment, group C -- vitamin B~12~ (2 mg/kg) treatment, group D -- dexamethasone (1 mg/kg) and vitamin B~12~ (2 mg/kg) treatment. \*p \< 0.05 vs. group A. \#p \< 0.05 vs. group B and C](AMS-8-19716-g001){#F0001}

Dexamethasone and vitamin B~12~ synergistically increase SCV of the injured sciatic nerves {#S20012}
------------------------------------------------------------------------------------------

Electrophysiological analysis demonstrated that the SCV of the injured sciatic nerves was increased in all groups with the duration of treatment. However, SCV in different groups showed no significant differences at the same time point of 1, 7 or 14 days after the injury. Notably, 21 days after the injury, SCV was increased to 22.85 ±4.35, 23.82 ±2.46, and 26.46 ±3.19 in group B, C and D, respectively, significantly higher than in group A (16.75 ±2.37) (*p* \< 0.05), but showed no differences among group B, C and D (*p* \> 0.05). Furthermore, 28 days after the injury, SCV was increased to 27.79 ±2.87, 28.87 ±1.92 and 36.65 ±3.76 in group B, C and D, respectively, significantly higher than in group A (17.92 ±3.98) (*p* \< 0.05). In addition, at this time the SCV was significantly higher in group D than in group B and C (*p* \< 0.05) with no significant difference between group B and C (*p* \> 0.05) ([Table I](#T0001){ref-type="table"}). These results suggest that dexamethasone and vitamin B~12~ synergistically increase SCV of the injured sciatic nerves.

###### 

SCV of the injured sciatic nerves in different groups

  Group   *n*   1 d.a.o.      7 d.a.o.      14 d.a.o.     21 d.a.o.                                       28 d.a.o.
  ------- ----- ------------- ------------- ------------- ----------------------------------------------- ----------------------------------------------------------------------------------
  A       6     12.32 ±3.21   13.45 ±3.57   15.39 ±4.53   16.75 ±2.37                                     17.92 ±3.98
  B       6     12.86 ±4.25   14.11 ±2.05   17.62 ±1.95   22.85 ±4.35[\*](#TF0001){ref-type="table-fn"}   27.79 ±2.87[\*](#TF0001){ref-type="table-fn"}
  C       6     13.37 ±2.64   15.74 ±3.32   17.29 ±3.36   23.82 ±2.46[\*](#TF0001){ref-type="table-fn"}   28.87 ±1.92[\*](#TF0001){ref-type="table-fn"}
  D       6     11.93 ±4.51   15.96 ±2.26   20.55 ±3.31   26.46 ±3.19[\*](#TF0001){ref-type="table-fn"}   36.65 ±3.76[\*](#TF0001){ref-type="table-fn"} [\#](#TF0002){ref-type="table-fn"}

d.a.o. -- days after operation. SCV was expressed as x ± SD (m/s). Group A -- 0.9% saline treatment, group B -- dexamethasone (1 mg/kg) treatment, group C -- vitamin B~12~ (2 mg/kg) treatment, group D -- dexamethasone (1 mg/kg) and vitamin B~12~ (2 mg/kg) treatment.

Value of p \< 0.05 vs. group A at 21 day and 28 day.

p \< 0.05 vs. group B and C at 28 day

Dexamethasone and vitamin B~12~ synergistically increase BDNF expression in the injured sciatic nerves {#S20013}
------------------------------------------------------------------------------------------------------

By immunohistochemical staining, the expression of BDNF, GDNF, NT-3 and IL-6 in the injured sciatic nerves (left side) and normal control sciatic nerves (right side) was detected. The results showed that in the control sciatic nerves, the axons were closely arranged in cords and BDNF, NT-3, IL-6 and GDNF were mildly expressed in the cytoplasm ([Figure 2](#F0002){ref-type="fig"}). Fourteen days after the injury, the sciatic nerves underwent degeneration and BDNF expression was slightly increased in each group but the staining was stronger in group B, C and D than in group A. However, the expression of NT-3, IL-6 and GDNF showed no significant changes in each group. Twenty-eight days after the injury, in group A the axons remained disarranged and BDNF expression was significantly decreased compared to the normal control (*p* \< 0.05). The arrangement of axons was improved in group B, C and D, especially in group D ([Figure 2](#F0002){ref-type="fig"}). BDNF expression was increased in group B, C and D with the highest expression level observed in group D (*p* \< 0.05 compared to group B and C). Similarly, the expression of NT-3, IL-6 and GDNF showed no significant changes in each group ([Table II](#T0002){ref-type="table"}).

![Immunohistochemical staining of BDNF, GDNF, NT-3 and IL-6 in the sciatic nerves in different groups. **A** -- Mild staining of BDNF in the control uninjured sciatic nerve. Organized arrangement of axons was obvious. **B** -- Weak staining of BDNF in the injured sciatic nerve in group A at 28 day. The axons were disarranged. **C** -- Strong staining of BDNF (indicated by green arrow) in the injured sciatic nerve in group B at 28 day. The axons were better arranged. **D** -- Strong staining of BDNF (indicated by green arrow) in the injured sciatic nerve in group C at 28 day. The axons were better arranged. **E** -- Very strong staining of BDNF (indicated by black arrow) in the injured sciatic nerve in group D at 28 day. The axons were well arranged. **F** -- Strong staining of GDNF (indicated by red arrow) in the injured sciatic nerve in group D at 14day. **G-I** -- Mild staining of GDNF (G), NT-3 (H) and IL-6 (I) in the injured sciatic nerve in group D at 28 day, although the axons were well arranged.\
Group A -- 0.9% saline treatment, group B -- dexamethasone (1 mg/kg) treatment, group C -- vitamin B~12~ (2 mg/kg) treatment, group D -- dexamethasone (1 mg/kg) and vitamin B~12~ (2 mg/kg) treatment. Amplification 200×](AMS-8-19716-g002){#F0002}

###### 

Scores of immunohistochemical staining of BDNF, NT-3, IL-6 and GDNF in the sciatic nerves in different groups

  Group      BDNF                                                                                                                     NT-3           IL-6           GDNF
  ---------- ------------------------------------------------------------------------------------------------------------------------ -------------- -------------- --------------
  Control    159.35 ±3.49                                                                                                             157.44 ±2.98   161.79 ±1.88   158.85 ±2.77
  A 14 day   161.72 ±2.78                                                                                                             155.32 ±1.66   158.69 ±1.06   167.36 ±2.13
  28 day     141.59 ±3.62[\*](#TF0003){ref-type="table-fn"}                                                                           142.52 ±2.21   147.35 ±2.36   147.04 ±1.69
  B 14 day   168.42 ±2.86                                                                                                             156.14 ±3.11   159.92 ±1.61   169.17 ±2.05
  28 day     173.25 ±2.23[\*](#TF0003){ref-type="table-fn"} [\#](#TF0004){ref-type="table-fn"}                                        143.26 ±1.31   145.63 ±1.92   148.86 ±1.09
  C 14 day   169.26 ±1.98                                                                                                             154.29 ±2.28   156.81 ±2.09   168.06 ±1.38
  28 day     178.58 ±1.56[\*](#TF0003){ref-type="table-fn"} [\#](#TF0004){ref-type="table-fn"}                                        146.87 ±2.02   144.39 ±1.08   149.53 ±2.46
  D 14 day   171.47 ±2.25[\*](#TF0003){ref-type="table-fn"}                                                                           155.83 ±3.26   154.04 ±2.53   168.79 ±1.19
  28 day     191.63 ±1.65[\*](#TF0003){ref-type="table-fn"} [\#](#TF0004){ref-type="table-fn"} [\*\*](#TF0005){ref-type="table-fn"}   143.19 ±2.66   146.57 ±1.07   145.25 ±1.86

The score was expressed as x ± SD (A value). Group A -- 0.9% saline treatment, group B -- dexamethasone (1 mg/kg) treatment, group C -- vitamin B~12~ (2 mg/kg) treatment, group D -- dexamethasone (1 mg/kg) and vitamin B~12~ (2 mg/kg) treatment.

p \< 0.05 vs. control.

p \< 0.05 vs. group A at 28 day.

p \< 0.05 vs. group B and C at 28 day

To confirm that dexamethasone and vitamin B~12~ specially increase BDNF expression in the injured sciatic nerves, we performed RT-PCR analysis on the sciatic nerves collected from different groups on day 28 ([Figure 3](#F0003){ref-type="fig"}). The results showed that mRNA level of BDNF was significantly increased in group B, C and D compared to group A (*p* \< 0.05). In addition, mRNA level of BDNF was significantly higher in group D than in group B and C (*p* \< 0.05). However, mRNA levels of NT-3, IL-6 and GDNF showed no significant changes in each group ([Table III](#T0003){ref-type="table"}). Taken together, both immunohistochemistry and RT-PCR analysis demonstrated that dexamethasone and vitamin B~12~ specially increase BDNF expression in the injured sciatic nerves.

![RT-PCR analysis of BDNF, GDNF, NT-3 and IL-6 mRNA levels in the sciatic nerves in different groups at 28 day. The analysis was performed in 3 in dependent experiments and representative images are shown. β-actin was the internal control\
Group A -- 0.9% saline treatment, group B -- dexamethasone (1 mg/kg) treatment, group C -- vitamin B~12~ (2 mg/kg) treatment, group D -- dexamethasone (1 mg/kg) and vitamin B~12~ (2 mg/kg) treatment](AMS-8-19716-g003){#F0003}

###### 

mRNA level of BDNF, NT-3, IL-6 and GDNF in the sciatic nerves in different groups at 28 day

  Group   BDNF                                                                              NT-3         IL-6         GDNF
  ------- --------------------------------------------------------------------------------- ------------ ------------ ------------
  A       0.03 ±0.01                                                                        0.15 ±0.03   0.07 ±0.02   0.12 ±0.05
  B       0.26 ±0.05[\*](#TF0006){ref-type="table-fn"}                                      0.12 ±0.02   0.05 ±0.01   0.09 ±0.01
  C       0.29 ±0.03[\*](#TF0006){ref-type="table-fn"}                                      0.14 ±0.05   0.04 ±0.03   0.08 ±0.04
  D       0.43 ±0.12[\*](#TF0006){ref-type="table-fn"} [\#](#TF0007){ref-type="table-fn"}   0.11 ±0.03   0.02 ±0.02   0.06 ±0.03

The mRNA level was expressed as x ± SD with mRNA level of β-actin set as 1. Group A -- 0.9% saline treatment, group B -- dexamethasone (1 mg/kg) treatment, group C -- vitamin B~12~ (2 mg/kg) treatment, group D -- dexamethasone (1 mg/kg) and vitamin B~12~ (2 mg/kg) treatment.

p \< 0.05 vs. group A.

p \< 0.05 vs. group B and C

Dexamethasone and vitamin B~12~ synergistically promote regeneration of injured sciatic nerves {#S20014}
----------------------------------------------------------------------------------------------

Finally we performed morphological analysis on the injured sciatic nerves in different groups on day 28. In group A, the myelin sheath was seriously damaged and many vacuoles were formed in the middle of the axons. In group B and C, a number of Schwann cells were formed. In addition, neovascularization and the formation of myelin sheath with thin walls were observed. In group D, the proliferation of Schwann cells and the formation of myelinated nerve fibers were obvious. The regeneration of myelinated fibers in the injured sciatic nerves in the different groups on day 28 is summarized in [Table IV](#T0004){ref-type="table"}.

###### 

Regeneration of myelinated fibers in the injured sciatic nerves in different groups at 28 day

  Group     Myelinated fiber number                         Axon diameter \[µm\]                                                              Myelin sheath thickness \[µm\]
  --------- ----------------------------------------------- --------------------------------------------------------------------------------- --------------------------------
  Control   106.3 ±12.5                                     2.96 ±0.15                                                                        3.54 ±0.41
  A         46.4 ±18.2                                      0.97 ±0.06                                                                        2.58 ±0.23
  B         73.5 ±9.4[\*](#TF0008){ref-type="table-fn"}     1.96 ±0.27[\*](#TF0008){ref-type="table-fn"}                                      3.36 ±0.58
  C         78.4 ±8.7[\*](#TF0008){ref-type="table-fn"}     1.78 ±0.35[\*](#TF0008){ref-type="table-fn"}                                      3.41 ±0.33
  D         97.2 ±14.88[\#](#TF0009){ref-type="table-fn"}   2.56 ±0.38[\*](#TF0008){ref-type="table-fn"} [\#](#TF0009){ref-type="table-fn"}   3.43 ±0.47

Data are expressed as x ± SD. Group A -- 0.9% saline treatment, group B -- dexamethasone (1 mg/kg) treatment, group C -- vitamin B~12~ (2 mg/kg) treatment, group D -- dexamethasone (1 mg/kg) and vitamin B~12~ (2 mg/kg) treatment.

p \< 0.05 vs. group A.

p \< 0.05 vs. group B and C

Discussion {#S0015}
==========

Dexamethasone and vitamin B~12~ are used for the clinical treatment of nerve injury. Dexamethasone is a synthetic steroid hormone frequently used in the treatment of nervous system injury and inflammation due to its strong anti-inflammatory effects, while vitamin B~12~ coenzyme is involved in a variety of main metabolic reactions. The mechanisms underlying the neurotrophic effects of dexamethasone and vitamin B~12~ remain elusive.

Neural regeneration is a very complex process and Schwann cells play an important role in the promotion of regeneration after nerve injury \[[@CIT0007]\]. After peripheral nerve injury, the distal axon myelin degenerates, and the degenerated axons and myelin undergo phagocytosis by Schwann cells or macrophages \[[@CIT0008]\]. Schwann cells not only secrete neurotrophins but also produce basement membrane and myelin to promote the regeneration of axon myelination \[[@CIT0009]\]. Numerous recent studies have focused on the differentiation of stem cells to Schwann cells as a promising approach for neural regeneration \[[@CIT0010]--[@CIT0012]\].

In this study we employed a variety of approaches to perform morphological and functional analysis on rat sciatic nerves subjected to injury and treatment by dexamethasone or vitamin B~12~. Morphologically, by electron microscopy we observed that compared to treatment with dexamethasone or vitamin B~12~ alone, treatment with both agents led to a much larger number of Schwann cells and myelinated nerve fibers. In addition, the diameter of the axons was larger. These results suggest that dexamethasone or vitamin B~12~ promoted the regeneration of myelinated nerve fibers and the proliferation of Schwann cells. Functionally, we confirmed that treatment with dexamethasone and vitamin B~12~ led to the recovery of SFI and SCV in the injured sciatic nerves. Furthermore, we demonstrated that treatment with dexamethasone and vitamin B~12~ led to the increased expression of BDNF in the injured sciatic nerves at both mRNA and protein levels, without significant effects on the expression of GDNF, NT-3 and IL-6. Interestingly, a recent study reported that adipose-derived stem cells stimulated the regeneration of peripheral nerves through the secretion of BDNF, which promoted nerve healing and axon growth \[[@CIT0013]\]. Based on our results we postulate that dexamethasone and vitamin B~12~ promote the regeneration and functional recovery of the injured sciatic nerves via the upregulation of BDNF expression. Nevertheless, further studies are necessary to elucidate the mechanism by which dexamethasone and vitamin B~12~ could upregulate BDNF expression in peripheral nerves.

In conclusion, in this study we demonstrated that dexamethasone and vitamin B~12~ promote peripheral nerve repair in a rat model of sciatic nerve injury through the upregulation of BDNF expression. These findings provide new insight into the neurotrophic effects of dexamethasone and vitamin B~12~ and support the application of these agents in clinical treatment of peripheral nerve injury.
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